Overview

Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)

Status:
Completed
Trial end date:
2008-12-10
Target enrollment:
Participant gender:
Summary
Trial to determine the maximum tolerated dose (MTD) based on safety and tolerability of MK-8777 (Org 26576, SCH 900777) in participants with major depressive disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.